Cranial magnetic resonance imaging in the staging of HER2-positive breast cancer patients

Onkologie

Volumn 36, Issue 4, 2013, Pages 176-181

  Kaplan, Muhammet A ^a,b   Inal, Ali ^a   Kucukoner, Mehmet ^a   Urakci, Zuhat ^a   Ekici, Faysal ^a   Firat, Ugur ^a   Zincircioglu, Seyit B ^b   Isikdogan, Abdurrahman ^a  

^a Department of Medical Oncology ^*  (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Asymptomatic brain metastases; Breast cancer; HER2 overexpression

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SURVIVAL TIME;

ADULT; AGED; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; RECEPTOR, ERBB-2; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TURKEY;

EID: 84876168016     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000349950     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Lin N, Bellon J, Winer E: CNS metastases in breast cancer. J Clin Oncol 2004;22:3608-3617.
3. Kleihues P, Cavenee W: Pathology and genetics of tumors of the nervous system; in: World Health Organization Classification of Tumours. Lyon, IARC Press, 2000.
4. Chang E, Lo S: Management of central nervous system metastases from breast cancer. Oncologist 2003;8:398-410.
5. Sawaya R, Bindal R, Lang F, et al.: Metastatic tumors; in Kaye AH, Laws ER Jr (eds): Brain Tumors: An Encyclopedic Approach. New York, Churchill Livingston, 2001, pp 999-1026.
6. Lassman A, De Angelis L: Brain metastases. Neurol Clin 2003;21:1-23.
7. Leyland-Jones B: Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases. J Clin Oncol 2009;27:5278-5286.
8. Sjögren S, Inganas M, Lindgren A, Holmberg L, Bergh J: Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol 1998;16:462-469.
9. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-182.
10. Owens MA, Horten BC, Da Silva MM: HER2-amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6,556 breast cancer tissues. Clin Breast Cancer 2004;5:63-69.
11. Sinard JH: Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol 2001; 70:333-343.
12. Miller KD, Weathers T, Haney LG, et al.: Occult central nervous system involvement in patients with metastatic breast cancer: Prevalence, predictive factors, and impact on overall survival. Ann Oncol 2003;14:1072-1077.
13. Niwińska A, Tacikowska M, Pieńkowski T: Occult brain metastases in HER2-positive breast cancer patients: frequency and response to radiotherapy. Acta Oncol 2007;46:1027-1029.
14. Niwińska A, Tacikowska M, Murawska M: The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. Int J Radiat Oncol Biol Phys 2010;77:1134-1139.
15. Tsukada Y, Fouad A, Pickren JW, Lane WW: Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983;52:2349-2354.
16. Amer M: Chemotherapy and pattern of metastases in breast cancer patients. J Surg Oncol 1982;19:101-105.
17. Hagemeister F, Buzdar A, Luna M, Blumenschein GR: Causes of death in breast cancer. Cancer 1980;46:162-167.
18. Aronson S, Garcia J, Aronson B: Metastatic neoplasms of the brain: their frequency in relation to age. Cancer 1964;5:558-563.
19. de la Monte S, Hutchins G, Moore G: Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 1988;19:529-534.
20. Lesse S, Netsky M: Metastasis of neoplasms to the central nervous system and meninges. AMA Arch Neurol Psychiatry 1954;72:133-153.
21. Abrams H, Spiro R, Goldstein N: Metastasis in carcinoma: analysis of 1000 autopsied cases. Cancer 1950;3:74-85.
22. Viadana E, Cotter R, Pickren JW, Bross ID: An autopsy study of metastatic sites of breast cancer. Cancer Res 1973;33:179-181.
23. Cifuentes N, Pickren JW: Metastases from carcinoma of mammary gland: an autopsy study. J Surg Oncol 1979;11:193-205.
24. Cho SY, Choi HY: Causes of death and metastatic patterns in patients with mammary cancer. Tenyear autopsy study. Am J Clin Pathol 1980;73:232-234.
25. Posner J, Chernik N: Intracranial metastases from systemic cancer. Adv Neurol 1978;19:579-591.
26. Lamvec J, Zidar A: Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. Arch Pathol Lab Med 1991;115:507-510.
27. Lai R, Dang CT, Malkin MG, et al.: The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer 2004;101:810-816.
28. Tomasevic ZI, Rakocevic Z, Tomasevic ZM, et al.: Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients? J BUON 2012; 17:249-253.
29. Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S; EORTC Radiation Oncology Group and Lung Cancer Group: Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-672.
30. Paumier A, Cuenca X, Le Péchoux C: Prophylactic cranial irradiation in lung cancer. Cancer Treat Rev 2011;37:261-265.